Autoimmune Diseases (original) (raw)
Latest News for: autoimmune diseases
Can stress trigger autoimmune disease? Doctor explains how it can impact your physiological functions and ...
Hindustan Times 16 Jun 2026
Venus Williams was diagnosed with Sjögren’s syndrome, an autoimmune disease so exhausting she could barely ...
SpaceDaily 14 Jun 2026
She had been diagnosed with Sjögren’s syndrome, an autoimmune disease that attacks the body’s moisture-producing glands and leaves many patients too drained to get out of bed ... disease.
Akeso's Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio
The Elkin Tribune 12 Jun 2026
HONG KONG, June 11, 2026 /PRNewswire/ -- Akeso, Inc.
DWP confirms full list of 10 autoimmune diseases that qualify for �114 weekly payment
Manchester Evening News 10 Jun 2026
In total, the DWP lists ten autoimmune diseases that qualify for PIP payments ... .
Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China
Lincoln Times-News 10 Jun 2026
... autoimmune diseases, solid tumors and hematological malignancies .
Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases (Form 8-K) (Cullinan Therapeutics Inc)
Public Technologies 10 Jun 2026
Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases ... Treatment-refractory autoimmune diseases driven by long-lived plasma cells.
A revolutionary cancer treatment could transform autoimmune disease
Floyd County Chronicle 09 Jun 2026
Knowable Magazine reports on a revolutionary CAR T-cell therapy, originally for cancer, now showing promise for autoimmune diseases like MS, offering hope with risks ... .
Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases (Form 8-K) (Cartesian Therapeutics Inc)
Public Technologies 09 Jun 2026
) Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases ... in autoimmune diseases.
ATG-207 Shows Promise in Modulating T Cells for Autoimmune Disease Treatment
NDTV 08 Jun 2026
Proteomic analysis revealed that ATG-207 markedly modulates functional remodeling of primary T cells ... .
GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease (American Heart Association)
Public Technologies 06 Jun 2026
) GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease ... Obesity and autoimmune disease are each associated with a higher risk of cardiovascular and blood clot events.
China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong ...
The Eagle-Tribune 05 Jun 2026
SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio ...
China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange
PR Newswire 05 Jun 2026
Founded in 2020, LongBio Pharma focuses on in-house discovery and development of biopharmaceuticals targeting on allergic and autoimmune diseases ... hematology, nephrology and other autoimmune diseases.
Cullinan Therapeutics to Host Immunology Day to Showcase Promising Initial Clinical Data in Autoimmune Diseases ...
Nasdaq Globe Newswire 26 May 2026
New and updated clinical data to be presented from over 30 patients across systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) studies� ... .